We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.36B
AUM Growth
-$370M
Cap. Flow
-$116M
Cap. Flow %
-2.16%
Top 10 Hldgs %
30.29%
Holding
272
New
25
Increased
53
Reduced
155
Closed
28

Top Buys

Rank Stock Value
1
CP icon
Canadian Pacific Kansas City
CP
+$80.1M
2
META icon
Meta Platforms (Facebook)
META
+$49.8M
3
GTLS
Chart Industries
GTLS
+$45.7M
4
WOLF icon
Wolfspeed
WOLF
+$30.1M
5
MSGS icon
Madison Square Garden
MSGS
+$19.9M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$46.5M
2
ENPH icon
Enphase Energy
ENPH
+$38.5M
3
TSLA icon
Tesla
TSLA
+$35M
4
LFG
Archaea Energy Inc.
LFG
+$29.8M
5
CALX icon
Calix
CALX
+$29.5M

Sector Composition

Rank Sector Weight
1 Technology 33.08%
2 Healthcare 19.9%
3 Consumer Discretionary 17.94%
4 Industrials 9.82%
5 Communication Services 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTOL icon
226
Bristow Group
VTOL
$1.25B
$300K 0.01%
+11,074
New +$289K
RNAM
227
DELISTED
Avidity Biosciences
RNAM
$298K 0.01%
+13,444
New +$200K
DAVA icon
228
Endava
DAVA
$156M
$287K 0.01%
3,746
-5,523
-60% -$411K
NEX
229
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$285K 0.01%
30,829
-410
-1% -$4.01K
ENFN
230
DELISTED
Enfusion, Inc.
ENFN
$280K 0.01%
28,946
+172
+0.6% +$1.94K
VZLA
231
Vizsla Silver
VZLA
$1.31B
$278K 0.01%
241,903
-1,127,240
-82% -$1.3M
SHEN icon
232
Shenandoah Telecom
SHEN
$641M
$267K 0.01%
16,796
-346
-2% -$6.33K
BBIO icon
233
BridgeBio Pharma
BBIO
$13.7B
$248K ﹤0.01%
32,539
-15,861
-33% -$152K
VIRX
234
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$236K ﹤0.01%
161,507
-100
-0.1% -$292
CRDO icon
235
Credo Technology Group
CRDO
$28.7B
$230K ﹤0.01%
17,275
-6
-0% -$80
STOK icon
236
Stoke Therapeutics
STOK
$1.81B
$209K ﹤0.01%
22,604
-35,260
-61% -$367K
RELY icon
237
Remitly
RELY
$4.64B
$208K ﹤0.01%
18,158
-51
-0.3% -$529
PRVB
238
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$199K ﹤0.01%
+18,842
New +$152K
EB
239
DELISTED
Eventbrite
EB
$172K ﹤0.01%
29,301
– –
PATH icon
240
UiPath
PATH
$7.45B
$159K ﹤0.01%
12,525
-17,424
-58% -$215K
FTHM icon
241
Fathom Holdings
FTHM
$19.6M
$141K ﹤0.01%
33,194
-22,006
-40% -$104K
CURV icon
242
Torrid Holdings
CURV
$220M
$132K ﹤0.01%
44,641
– –
COMP icon
243
Compass
COMP
$7.9B
$110K ﹤0.01%
47,326
– –
RDFN
244
DELISTED
Redfin
RDFN
$81.7K ﹤0.01%
19,266
– –
AIP icon
245
Arteris
AIP
$1.01B
– –
-601,264
Closed -$4M
ALEC icon
246
Alector
ALEC
$234M
– –
-24,703
Closed -$234K
AUPH icon
247
Aurinia Pharmaceuticals
AUPH
$2.13B
– –
-179,090
Closed -$1.35M
BCRX icon
248
BioCryst Pharmaceuticals
BCRX
$2.08B
– –
-303,642
Closed -$3.83M
CNM icon
249
Core & Main
CNM
$7.64B
– –
-229,995
Closed -$5.23M
DNTH icon
250
Dianthus Therapeutics
DNTH
$5.93B
– –
-44,076
Closed -$994K
7 8 9
10
11

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Gilder Gagnon Howe & Co held 272 positions worth $5.36B, down 6.5% from $5.73B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2022 filing shows 25 new, 53 increased, 155 reduced and 28 closed positions. Its largest new stake was Chart Industries: 284,553 shares worth $32.8M. The largest sale was Novo Nordisk, an estimated $46.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Gilder Gagnon Howe & Co's largest Q4 2022 buy was Chart Industries: 284,553 shares worth $32.8M.
  • Gilder Gagnon Howe & Co added most to Canadian Pacific Kansas City in Q4 2022, an estimated $80.1M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $46.5M.
  • Gilder Gagnon Howe & Co fully exited Archaea Energy Inc. in Q4 2022, selling an estimated $29.8M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 30% of its $5.36B portfolio in Q4 2022.
  • Gilder Gagnon Howe & Co opened 25 new positions and closed 28 in Q4 2022.
  • Gilder Gagnon Howe & Co's portfolio value fell 6.5% quarter-over-quarter to $5.36B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2022, filed 14 Feb 2023.